FibroBiologics, Inc. FBLG 深 沪
交易中 03-25 12:11:12 美东时间
0.2699
+0.013
+4.90%
华盛通- 最 高0.2699
- 今 开0.255
- 成交量 21.99万股
- 最 低 0.2535
- 昨 收 0.2573
- 总市值 1824.38万
- 52周最高 1.53
- 市盈率 静 --
- 换手率 0.33%
- 52周最低 0.2201
- 委 比 -66.67%
- 总股本 6759.47万
- 历史最高 55.00
- 量 比 0.72
- 振 幅 6.37%
- 历史最低 0.2201
- 每 手 1
- 风险率 0.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FibroBiologics Completes Onboarding Of Clinical Sites For Phase 1/2 Clinical Trial Evaluating Safety And Efficacy Of CYWC628 For Treatment Of Refractory DFUs
FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases
03-05 21:32
FibroBiologics Issued New U.S. Patent Entitled Fibroblast Cell Therapy for Treatment of Osteoporosis
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for
03-02 21:37
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
D. Boral Capital Maintains Buy on FibroBiologics, Lowers Price Target to $7
D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and lowers the price target from $15 to $7.
02-26 05:34
FibroBiologics, Inc. - Common Stock Q4 EPS $(0.03) Beats $(0.09) Estimate
FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.09) by 67.39 percent. This is a 66.67 percent increase over losses of
02-25 06:22
FibroBiologics Receives Nasdaq Compliance Extension Through April 13
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for
02-23 21:38
FibroBiologics Issued Canadian IP Office Patent
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for
02-05 21:38
Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Align Technology Inc (NASDAQ:ALGN) rose sharply in pre-market trading...
02-05 17:34
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
